Story Navigation
-
Access to HealthcareNovartis AccessHeart FailureAccess to HealthcareNegative impact of the IRA on patient access to innovative treatments
At Novartis, we are constantly pushing the limits of science to develop and deliver transformative medicines that fight disease and help people live life on their terms.
Access to Healthcare -
People and CultureCareersSocial CommitmentWorking at NovartisEvery number has a story – my journey to Novartis as a Refugee
The current refugee crisis is one of the world's greatest humanitarian challenges. Svitlana shares her story of her journey to Novartis and how her work as part of the Giving and Volunteering team is opening the doors to refugees and other marginalized groups and allowing our people to make a difference by helping those who are most vulnerable.
People and Culture -
People and CultureCareersInnovationLocal ImpactSocial CommitmentWorking at NovartisIs Diversity, Equity and Inclusion (DEI) really that important?
We think so and here are just some of the reasons why: we believe our workplace should reflect today’s emerging workforce; every culture needs diversity to thrive; and it supports fair treatment and opportunities for all our people.
People and Culture -
DiscoveryBiomedical ResearchCancerClinical ResearchA legacy of blood cancer innovation
Building on more than two decades of chronic myeloid leukemia research, the R&D teams at Novartis pursued an investigational treatment unlike any other.
Discovery -
People and CultureBiomedical ResearchCareersWomen in ScienceDrug DiscoveryWorking at NovartisA personal journey full circle, from curiosity about life on Earth to transformative therapies at Novartis
From curiosity about life on Earth to transformative therapies at Novartis. Michelle L Krishnan, Executive Director, MD PhD.
People and Culture -
People and CultureCareersEmerging TechnologyFuture of HealthcareInnovationWorking at NovartisFrom black holes to AI driven drug discovery – collaboration wins the day
Dr Bülent Kızıltan, Global Head of AI & Computational Sciences
People and Culture -
From Our LabsCancerDrug DevelopmentOncologyReimagine MedicineTargeted TherapyDrug delivery, service delivery, and the future of cancer care
State-of-the-art Novartis manufacturing facility in Indianapolis fortifies the foundation of an entirely new paradigm in pharmaceutical drug delivery.
From Our Labs -
Patient PerspectivesPatient VoicesOncologyCancerClinical TrialsListening to the CML patient community
Improving the patient experience and removing potential barriers to clinical trial participation
Patient Perspectives -
People and CultureWorking at NovartisBiomedical ResearchData ScienceDrug DiscoveryGene TestingHow collaboration can enhance your science career
Kumar Veerapen, Senior Expert I Data Science
People and Culture -
Patient PerspectivesDisease AwarenessLiving With DiseasePatient VoicesGiving voice to people with a misunderstood disease
Shanelle Gabriel was diagnosed with lupus — a chronic autoimmune disease that mostly affects women of African American and Hispanic descent — while she was at college. Today, as a singer, poet and advocate, she uses her voice to highlight challenges faced by people living with this complex and often misunderstood condition.
Photos: Brent Stirton, Getty Images for Novartis
Patient Perspectives -
Access to HealthcareAccess to HealthcareAfricaLocal ImpactSocial CommitmentA partnership against epilepsy
Parts of Cameroon have rates of epilepsy that are among the highest in the world. Despite the availability of effective therapies, poverty, a lack of medical resources and superstition about the causes of epilepsy often lead to inadequate treatment and social exclusion for people living with the neurological condition. Novartis is working with a Catholic mission on the ground in a central part of the country to overcome these barriers and improve care.
Photos: Bjoern Myhre, Novartis
Access to Healthcare -
DiscoveryEnvironmental SustainabilityLocal ImpactSocial CommitmentWater project revives rural community in India
Novartis is aiming for water neutrality in our own operations by 2030. In India, we are contributing to this goal through a project near Hyderabad with a nonprofit organization. By tackling both water scarcity and the deprivation it causes, the project has revived the community.
Photos: Bjoern Myhre, Novartis
Discovery
Pagination
- ‹ Previous page
- 1
- 2
- 3
- 4
- 5
- 6
- 7
- …
- 32
- › Next page